[1] 曹宁.肾功能衰竭患者采用不同血液透析膜材料的生物相容性对比分析[J].中国组织工程研究, 2012,16(25): 4727-4734.
[2] 于泓,姚观平,任飞,等.羊膜间充质干细胞移植治疗急性肾损害[J]. 中国组织工程研究, 2012,16(49): 9196-9200.
[3] 王巍巍,姜燕,王葳,等.低氧诱导因子1α基因修饰脂肪干细胞修复小鼠急性肾损伤[J].中国组织工程研究,2012, 16(41): 7651- 7657.
[4] 毕凌云,郭金岗,张瑞霞,等.干细胞因子和粒细胞集落刺激因子动员自身骨髓干细胞治疗缺血再灌注肾损伤[J].中国组织工程研究,2012,16(41):7681-7687.
[5] 王葳,王巍巍,张金元.干细胞移植在急性肾损伤中的应用及研究进展[J].中国组织工程研究,2012,16(36): 6805-6809.
[6] 陶佳意,米华,莫曾南,等.姜黄素预处理及缺血后处理对大鼠肾脏缺血再灌注损伤的保护作用[J].中国组织工程研究,2012, 16(53):10015-10020.
[7] Wu Y, Zhao RC. The Role of Chemokines in Mesenchymal Stem Cell Homing to Myocardium. Stem Cell Rev. 2012; 8(1):243-250.
[8] Ma T, Grayson WL, Frohlich M, et al. Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog. 2009;25 (1): 32-42.
[9] Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol. 2009;219 (2): 271-275.
[10] Phillips AW, Johnston MV, Fatemi A. The potential for cell-based therapy in perinatal brain injuries. Transl Stroke Res. 2013;4(2):137-148.
[11] Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382(6594): 829-833.
[12] Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203(9): 2201-2213.
[13] Ratajczak MZ, Majka M, Kucia M ,et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells. 2003;21(3): 363-371.
[14] Kubo M, Li TS, Kamota T ,et al. Increased expression of CXCR4 and integrin alphaM in hypoxia-preconditioned cells contributes to improved cell retention and angiogenic potency. J Cell Physiol. 2009;220(2): 508-514.
[15] Hung SC, Pochampally RR, Hsu SC, et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One. 2007;2(5): e416.
[16] Liu H, Liu S, Li Y ,et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One. 2012;7(4): e34608.
[17] Liu H, Xue W, Ge G ,et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun. 2010;401(4): 509-515.
[18] Ohnishi H, Mizuno S, Nakamura T. Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure. Am J Physiol Renal Physiol. 2008. 294(2): F326-335.
[19] Togel F, Isaac J, Hu Z ,et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005;67(5): 1772-1784.
[20] Pasha Z, Wang Y, Sheikh R ,et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008;77(1): 134-142.
[21] Tepper OM, Galiano RD, Capla JM ,et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-2786.
[22] Askari AT, Unzek S, Popovic ZB ,et al. Effect of stromal-cell- derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362(9385): 697-703.
[23] Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008;1195: 104-112.
[24] Gerber I, Gwynn AP. Differentiation of rat osteoblast-like cells in monolayer and micromass cultures. Eur Cell Mater. 2002;3: 19-30.
[25] Son BR, Marquez-Curtis LA, Kucia M ,et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006;24(5): 1254-1264.
[26] Wynn RF, Hart CA, Corradi-Perini C ,et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004; 104(9): 2643-2645.
[27] Janowska-Wieczorek A, Majka M, Kijowski J ,et al. Platelet- derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood. 2001;98(10): 3143-3149.
[28] Levesque JP, Hendy J, Takamatsu Y ,et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111(2): 187-196.
[29] Schioppa T, Uranchimeg B, Saccani A ,et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003; 198(9): 1391-1402.
[30] Martin-Rendon E, Hale SJ, Ryan D ,et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells. 2007;25(4): 1003-1012.
[31] Bosco MC, Puppo M, Santangelo C ,et al. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol. 2006; 177(3): 1941-1955.
[32] Ceradini DJ, Kulkarni AR, Callaghan MJ,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10(8): 858-864.
[33] Tarnowski M, Grymula K, Reca R ,et al. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res. 2010; 8(1): 1-14.
[34] Schutyser E, Su Y, Yu Y ,et al. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw. 2007;18(2): 59-70.
[35] Madden SL, Cook BP, Nacht M ,et al. Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol. 2004;165(2): 601-608.
[36] Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia. 2002; 16(10): 1992-2003.
[37] Petit I, Szyper-Kravitz M, Nagler A ,et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3(7): 687-694.
[38] Hattori K, Heissig B, Tashiro K ,et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97(11): 3354-3360.
[39] Peled A, Kollet O, Ponomaryov T ,et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/ stromal migration and engraftment of NOD/SCID mice. Blood. 2000;95(11): 3289-3296.
[40] Yamaguchi J, Kusano KF, Masuo O ,et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107(9): 1322-1328.
[41] Janowska-Wieczorek A, Marquez LA, Dobrowsky A ,et al. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol. 2000;28(11): 1274-1285.
[42] Kijowski J, Baj-Krzyworzeka M, Majka M,et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells. 2001;19(9): 453-466.
[43] Majka M, Janowska-Wieczorek A, Ratajczak J ,et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 2000; 96(13): 4142-4151.
[44] Lataillade JJ, Clay D, Dupuy C ,et al. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood. 2000; 95(3): 756-768.
[45] Broxmeyer HE, Kohli L, Kim CH ,et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol. 2003;73(5): 630-638.
[46] Bhakta S, Hong P, Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med. 2006;7(1): 19-24.
[47] Boldajipour B, Mahabaleshwar H, Kardash E ,et al. Control of chemokine-guided cell migration by ligand sequestration. Cell. 2008;132(3): 463-473.
[48] Knaut H, Schier AF. Clearing the path for germ cells. Cell. 2008;132(3): 337-339.
[49] Valentin G, Haas P, Gilmour D. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr Biol. 2007;17(12): 1026-1031.
[50] Dambly-Chaudiere C, Cubedo N, Ghysen A. Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev Biol. 2007;7: 23.
[51] Mazzinghi B, Ronconi E, Lazzeri E ,et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med. 2008; 205(2): 479-490.
[52] Lotan D, Sheinberg N, Kopolovic J ,et al. Expression of SDF-1/CXCR4 in injured human kidneys. Pediatr Nephrol. 2008;23(1): 71-77. |